Ucsf pd 1 trial eligibility - Maintenance Therapy in NSCLC - UCSF CME
This trial; Search. Functional Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 review of the University of California, San Francisco
A Phase II Clinical Trial of Pembrolizumab as Monotherapy Eligibility Criteria: Has received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2
Improving access to contraception and based and to identify the need for training on contraceptive eligibility and Speidel JJ, Darney PD, Brindis CD
My husband is a stage 4 melanoma patient at UCSF who has been on PD-1 for National Cancer Institute (NCI) and was accepted into a t-cell therapy clinical trial.
Expression of programmed death-ligand 1 (PD-L1) University of California, San Francisco, 1600 Divisadero St, Patient Eligibility
University of California San Francisco; UCSF Medical Subjects will be screened for eligibility within 14 days of the planned first dose of Cohort 1 - ATRT